3 Beaten-Down Stocks That Haven't Been This Cheap in Over 5 Years

Lululemon Athletica, Target, and Kimberly-Clark are trading near five-year lows, presenting potential value but also significant risks for investors. Lululemon's stock has plummeted 58% this year due to tariffs and reduced discretionary spending, with its 1% comparable sales growth indicating a slowdown, though its strong brand may facilitate a 1-2 year recovery. Target is down 33% amid challenging economic conditions impacting discretionary purchases, but a new CEO is initiating a major restructuring, potentially aiding a rebound within a similar timeframe. Kimberly-Clark, down over 20%, faces the most uncertainty following its perplexing $48.7 billion acquisition of Kenvue, which involves taking on substantial liabilities and a struggling business, making it the riskiest of the three with a tougher path to turnaround.

Analysis

Lululemon Athletica (LULU) has seen its stock plummet 58% this year, trading near March 2020 levels, primarily due to tariffs and a slowdown in discretionary consumer spending. The company reported a mere 1% comparable sales growth in its most recent quarter, signaling significant headwinds. Despite a seemingly cheap P/E of 11, this valuation is precarious if financial performance continues to deteriorate.

Target (TGT) is also experiencing pressure, with its stock down 33% this year, similarly near 2020 lows, as its business heavily relies on discretionary purchases amidst tough economic conditions. Net sales declined 1% to $25.2 billion in its last earnings report. However, the appointment of new CEO Michael Fiddelke and his immediate initiation of 1,800 corporate layoffs, the largest restructuring in a decade, indicates proactive efforts to improve profitability.

Kimberly-Clark (KMB), typically a blue-chip stock, has fallen over 20% this year, reaching 2018 lows, following its perplexing $48.7 billion acquisition of Kenvue. This acquisition introduces significant challenges, including Kenvue's struggling growth and potential legal liabilities related to talc-based products and Tylenol. Trading at 17 times trailing earnings, KMB is the most expensive of the three and faces the toughest path to recovery, with potential for further losses.

Key Decisions for Investors

• Monitor economic indicators and Lululemon's comparable sales growth for signs of a turnaround, considering its strong brand power could facilitate a recovery within 1-2 years if discretionary spending improves.
• Evaluate the effectiveness of Target's new CEO Michael Fiddelke's restructuring efforts and their impact on profitability, as the 10x earnings multiple offers a margin of safety for a potential rebound within 1-2 years.
• Exercise extreme caution or avoid Kimberly-Clark due to the significant risks associated with the Kenvue acquisition, including potential legal liabilities and the acquired entity's struggling growth, which could lead to further stock depreciation despite its current 20% decline.